Oruka Therapeutics (ORKA) Q1 2026 Earnings

12MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.64
-0.56
-0.48
-0.4

Details

Expected EPS
-0.636147
Actual EPS
-0.45
Surprise EPS
0.19
Surprise Percent
+29.26%

Description

Oruka Therapeutics (ORKA) has reported earnings of -0.45 per share for Q1 2026.

0 Comments

Share your thoughts